MR SOLUTIONS is a world leader in MRI technology, developer and manufacturer of the world’s first range of commercial, superconducting, cryogen-free (dry magnet), benchtop MRI systems. MRS accessorizes its preclinical MRI scanners with PET and SPECT modules for both sequential and simultaneous acquisition with MR data.Learn More
ESMRMB Congress 2019
Please join MR Solutions at the first ESMRMB Preclinical MRI Event Frontiers in Preclinical MRI: Where Imaging Sciences, Life Sciences and Medicine Meet on Oct. 2, 2019.
The meeting will give an overview of state-of-the-art preclinical MR as well as the clinical relevance and future directions of the field.
Engage with the preclinical and clinical community, and discuss the present and future of preclinical MRI research. We want to strengthen interdisciplinary bonds and foster translational work, so don’t miss this opportunity to connect with your peers and colleagues!
More information on the programme and registration available on the ESMRMB website.
MR Solutions’ multi-modality, cryogen free technology is recognised as the norm at the ISMRM meeting in Montreal
MR Solutions’ high field simultaneous PET-MR systems and large bore, 7T cryogen free MRI technology were seen to be game-changers by leading molecular imaging researchers at the 27th Annual Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM) , in Montreal last week. The accuracy and speed of acquisition of PET combined with high field MRI imaging is now viewed as the norm by academic laboratories across the world.
7T PET-MR workshop Simultaneous Imaging
Organized by the CGFL within the IMAPPI, Pharmimage, Pharmaco-imaging consortiums and MR Solutions, the workshop has been designed to be highly interactive with demonstrations of the new 7T integrated PET/MR system of MR Solutions. Three roundtables will be organized in order to present topics such as PET/MR imaging in the field of preclinical oncology, neurology, cardiovascular diseases and multimodal probes design. MR Solutions users group meeting
MR Solutions brings preclinical MRI to World Preclinical Congress in Boston
MR Solutions will be showing their latest state of the art 3T to 9.4T superconducting, cryogen-free MRI imaging technology with optional PET and SPECT imaging modalities on stand 407 at the 16th annual World Preclinical Congress in Boston on June 13th to 15th. The congress focusses on the very latest trends and technologies impacting the preclinical drug discovery and development world.
MR Solutions receives worldwide recognition with R&D 100 Award
MR Solutions’, revolutionary preclinical scanner MRS 7000, is an award winner at the US-based R&D 100 Awards. The 54th annual awards, held in Washington in November 2016, recognise the 100 most innovative technologies and services of the past year.
MR Solutions’ 3T MRI preclinical imaging system aids oncology research at Luxembourg
The NORLUX Neuro-Oncology Laboratory, an international research center which is part of the Luxembourg Institute of Health (LIH) has installed MR Solution’s - MRS 3017 - 3T cryogen-free MRI preclinical scanner.
Cryogen-free 7T simultaneous PET-MR preclinical imaging system at the Keck School of Medicine of the University of Southern California
MR Solutions to supply cryogen-free 7T simultaneous PET-MR preclinical imaging system for the study of Alzheimer’s and stroke at the Keck School of Medicine of the University of Southern California.
MR Solutions receives Queen’s Award for Enterprise at Buckingham Palace
MR Solutions, the Surrey-based preclinical imaging company, received royal approval when attending a reception at Buckingham Palace to receive the prestigious Queen’s Award for Enterprise (Innovation). This was achieved in recognition of their development of the world’s first commercial range of cryogen-free preclinical MRI scanners, which do not require liquid helium cooling, and the commercial success which has followed.
MR Solutions: New partner for Phase II and III of the IMAPPI project
MR Solutions, partner of the Integrated Magnetic resonance and Positron emission tomography in Preclinical Imaging (IMAPPI) consortium takes over the completion of phase 2 for sequential PET/MR imager, and phase 3 for simultaneous PET/MR imager.
Our unique MRI system design enables a broad range of applications, from preclinical imaging to food, industrial and commercial applications, offering superior soft tissue contrast and high spatial resolution.Learn More
New Products: New Cryogen-free MR models, New CT and new PET
MR Solutions: Imaging Innovations
1- New cryogen-free 9.4T MRI
2- New extra large bore 3T with 40cm diameter
3- Four new CT models for PET/CT, SPECT/CT and very high resolution CT
4- New PET and SPECT Benchtop system
5- EVO2+ New generation of spectrometer for clinical and preclinical MRI